Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Depreciation & Amortization (CF) (2024 - 2025)

Historic Depreciation & Amortization (CF) for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $385000.0.

  • Beta Bionics' Depreciation & Amortization (CF) rose 2068.97% to $385000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 4319.91%. This contributed to the annual value of $1.2 million for FY2024, which is 212.07% down from last year.
  • As of Q3 2025, Beta Bionics' Depreciation & Amortization (CF) stood at $385000.0, which was up 2068.97% from $347000.0 recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' Depreciation & Amortization (CF) registered a high of $385000.0 during Q3 2025, and its lowest value of $281000.0 during Q4 2024.